| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.12 | 0.03 |